Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time through ≥12 months post-TSHA-102...
Next generation, dual-use robotics and navigation platform allows for surgical guidance tailored to surgeon preference and the patient SOMERS POINT,...
A Platform Built for Clarity and ConnectionNEW YORK, June 24, 2026 /PRNewswire/ -- Digital Silk led the engagement from strategy...
Rapidly growing pharmaceutical services platform receives industry recognition NASHVILLE, Tenn., June 24, 2026 /PRNewswire/ -- Petauri, a purpose-built pharmaceutical services platform,...
In this free webinar, gain insight into how patient identification approaches can improve study efficiency in precision neurology programs. Attendees...
TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that...
NDA submission supported by positive Phase 3 data recently published in JAMA Neurology.Ecopipam is a first-in-class selective dopamine D1 receptor...
TEL AVIV, Israel and PARSIPPANY, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)...
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...
BOULDER, Colo., June 17, 2026 /PRNewswire/ -- Igniton is proud to announce that it has been honored with three 2025...
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore...
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-makingExpands partnering efforts with global pharmaceutical...
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-makingExpands partnering efforts with global pharmaceutical...
LOS ANGELES, June 16, 2026 /PRNewswire/ -- Nervonik, a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies,...
LOS ANGELES, June 16, 2026 /PRNewswire/ -- Nervonik, a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies,...
The new 'virtual biopsy' model predicts brain activity, therapy response, and side effects in patients with up to 3x greater...
The $400,000 prize honors five researchers who developed the first medical device to generate a human sense through a direct...
Harvard neuroscientist tells the D.C. Circuit that expanding marijuana access without fully addressing documented public health risks could have far...
RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe 2026 in Amsterdam, taking place from June 15...